Bringing Discoveries to Commercialization


2017 Translating Research into Practice Community Showcase

Thursday, October 19, 2017

On Wednesday, November 1, 2017, several of IUPUI’S distinguished faculty scholars will showcase their translational research and illustrate how they improve people’s lives at the IUPUI TRIP Community Showcase in the IUPUI Campus Center. These scholars have partnered with community members and others to translate their research into viable practices that improve our communities. Mark […]

Invention to Startup forum Friday, October 27th, 2017

Thursday, October 19, 2017

You are invited to the “Invention to Startup forum” at The Indiana Center of Biomedical Innovation (ICBI). The goal of the program is to support the advancement of translational research and lab discoveries into market-directed healthcare applications.  The program is designed to provide guidance and mentorship to academic scientists.   The next forum meeting is on  October 27th , see information below.   […]

Indiana Center for Biomedical Innovation Aims to Get Ideas to Market

Friday, October 6, 2017

The ICBI engaged local representatives from the medtech industry, like pharma giant Eli Lilly(NYSE: LLY) and Roche Diagnostics, to be part of its advisory council, which also includes experts in the legal, regulatory, and financial aspects of developing a biomedical startup. Industry reps will offer perspective on what kinds of needs are unfulfilled and meet with young startups […]

Calling all entrepreneurial researchers!

Friday, September 22, 2017

APPLICATIONS DUE TODAY I-CORPS Training • When: Oct. 19-20 and Nov. 17 • Where: HITS building at IUPUI • Summary: The “Introduction to Customer Discovery” course is a medical- and healthcare-focused program to help researchers and clinicians discover the commercial potential of their innovations. Apply by Sept. 22: AWARE Commercialization and Entrepreneurship Summit • When: […]

Allinaire, ICBI company received $1.9M in grant funding

Wednesday, September 20, 2017

Allinaire Therapeutics has been awarded a $1,670,000 Phase II SBIR grant from the National Heart, Lung, and Blood Institute (NHLBI) and a $213,000 Discovery Award from the department of Defence (DOD). Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. It is based on discoveries and intellectual property […]

Hoosier-Made ‘Ear-in-a-Dish’ Making Waves

Tuesday, May 2, 2017

Monon Bioventures LLC is working with Dr. Karl Koehler from the Indiana University School of Medicine on a so-called “ear-in-a-dish.” Koehler says the stem cell technology will allow scientists to better study the inner ear and the development of hearing loss. During an interview after winning Scientific Breakthrough of the Year at the 2016 Mira […]

Allinaire Therapeutics, a new Biotechnology Start-Up, Launches to Combat Lung Diseases

Wednesday, January 4, 2017

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. Allinaire Therapeutics is based on discoveries and intellectual property from the Indiana University School of Medicine, developed by scientific founders Irina Petrache, MD and Matthias Clauss, PhD. Dr. Petrache is currently the Chief of Pulmonary, Critical Care, and Sleep […]

Strategies for Accelerating Academic Drug Discovery

Monday, October 31, 2016

On October 31, 2016, Dr. Vincent Groppi, Director of Center for Discovery of New Medicines (CDNM), University of Michigan, presented a seminar on “ Innovative Strategies for Accelerating Academic Drug Discovery”.  The seminar was sponsored by CTSI and ICBI as a part of the Translational Research and Entrepreneurship Program.  Dr. Groppi discussed the innovative model that CDNM is pursuing to identify […]

Tumors’ alternative energy source could be new target for melanoma therapy

Tuesday, October 11, 2016

Melanoma tumors switch to an alternative energy system when they develop resistance to chemotherapy, making that alternative system an attractive target for new treatments, according to researchers at Indiana University School of Medicine. Malignant melanoma is one of the most lethal forms of cancer, responsible for 95 percent of skin cancer-related deaths. When the cancer […]

IU-based startup awarded $1.47M NIH grant to study atrial fibrillation, nerve activity

Monday, August 1, 2016

A life sciences company based on IU technology has received a two-year, $1,472,476 grant from the National Institutes of Health to help researchers determine if nerve activity is associated with a common heart rhythm disorder. Officials at Arrhythmotech LLC will use the STTR Phase II grant on new methods to study patients who are affected […]

1 2 3